Hospital
Henry Ford Health Providence Hospital
Henry Ford Health Providence Hospital was paid $72.76M by Medicaid between Jan 2018 and Dec 2024, across 437 billing codes. Its largest line is 99285, emergency room visit (most serious) — 21% of everything it billed.
33Billing provider infoHENRY FORD HEALTH PROVIDENCE HOSPITAL
NOVI, MI 48374
NOVI, MI 48374
33aNPI1144210253assigned 10/28/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$72.76M
24GClaims2,182,213
24DCodes billed437
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Michigan
Rank by total paid#15 of 86
Median peer was paid$21.55M
This provider vs. median3.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DAMSCHRODER, ROBIN controls 14+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 327,428 | $9.70M | |
| 2019 | 325,371 | $10.36M | |
| 2020 | 273,703 | $8.64M | |
| 2021 | 326,545 | $11.23M | |
| 2022 | 334,681 | $11.67M | |
| 2023 | 354,783 | $12.10M | |
| 2024incomplete | 239,702 | $9.06M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 21% | 47,093 | 43,957 | $15.19M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 73,316 | 68,228 | $12.06M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 11% | 62,747 | 58,992 | $7.94M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 7.5% | 105,933 | 97,139 | $5.46M |
| G0378 | Hospital observation service, per hour | 5.9% | 16,279 | 14,518 | $4.27M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.7% | 51,773 | 47,401 | $4.17M |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.7% | 30,972 | 26,353 | $1.20M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.5% | 6,587 | 6,495 | $1.10M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.3% | 11,302 | 9,883 | $951K |
| 80061 | Lipid panel | 1.3% | 2,791 | 2,715 | $911K |
| 71046 | Radiologic examination, chest; 2 views | 1.1% | 26,386 | 25,458 | $779K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 1.1% | 1,910 | 1,886 | $772K |
425 more codes
| 70450 | Computed tomography, head or brain; without contrast material | 1.1% | 11,456 | $768K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.0% | 7,931 | $755K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 7,178 | $710K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 1,517 | $699K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 12,632 | $599K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 3,462 | $560K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 32,250 | $531K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 21,646 | $510K |
| 71045 | Radiologic examination, chest; single view | <1% | 15,462 | $483K |
| 20610 | <1% | 3,263 | $483K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 19,151 | $472K |
| 93458 | <1% | 329 | $471K | |
| 82947 | <1% | 24,999 | $456K | |
| 76830 | Ultrasound, transvaginal | <1% | 7,883 | $395K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 5,135 | $395K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 24,760 | $393K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 1,222 | $388K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 8,363 | $375K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 6,063 | $367K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 3,107 | $305K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 4,887 | $275K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 1,532 | $270K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 62,283 | $268K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 9,160 | $252K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 4,372 | $197K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 467 | $185K |
| 62323 | <1% | 580 | $183K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 6,279 | $173K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 2,159 | $171K |
| 76801 | <1% | 3,295 | $156K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 9,297 | $148K |
| 93975 | <1% | 1,553 | $146K | |
| 72141 | <1% | 1,210 | $145K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 330 | $144K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 1,179 | $143K |
| 93971 | <1% | 3,411 | $142K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 11,193 | $139K |
| 93970 | <1% | 1,729 | $138K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 10,411 | $135K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 10,050 | $133K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 1,875 | $117K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 1,929 | $116K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 5,940 | $111K |
| 70496 | <1% | 1,578 | $108K | |
| 76642 | <1% | 3,144 | $103K | |
| 76770 | <1% | 2,069 | $102K | |
| 76536 | <1% | 2,181 | $100K | |
| 97161 | <1% | 1,985 | $97K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 35,873 | $96K |
| 10060 | <1% | 1,031 | $95K | |
| Q3014 | Telehealth originating site facility fee | <1% | 5,765 | $90K |
| 93017 | <1% | 2,907 | $87K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 3,099 | $87K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,797 | $76K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 8,888 | $73K |
| 93351 | <1% | 935 | $73K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 3,287 | $71K |
| 58558 | <1% | 54 | $70K | |
| 97162 | <1% | 1,532 | $67K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 1,377 | $66K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 10,156 | $65K |
| 59025 | Fetal non-stress test | <1% | 874 | $63K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 10,159 | $61K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 1,281 | $59K |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 5,404 | $57K |
| 71250 | <1% | 1,344 | $56K | |
| 73564 | <1% | 6,100 | $55K | |
| 72131 | <1% | 1,770 | $54K | |
| 90686 | <1% | 2,754 | $53K | |
| 70486 | <1% | 2,058 | $53K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 631 | $52K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 2,903 | $52K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 2,910 | $50K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 400 | $49K |
| 20611 | <1% | 317 | $48K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 5,240 | $48K |
| 36430 | <1% | 477 | $47K | |
| 77065 | Tomosynthesis, mammo | <1% | 1,045 | $44K |
| 73502 | <1% | 2,940 | $41K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 902 | $39K |
| 72110 | <1% | 1,262 | $38K | |
| 77066 | Tomosynthesis, mammo | <1% | 652 | $37K |
| 99385 | <1% | 1,323 | $36K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 49 | $36K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,486 | $35K |
| 73030 | <1% | 5,285 | $35K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 1,529 | $34K |
| 71271 | <1% | 663 | $34K | |
| 12001 | <1% | 1,249 | $33K | |
| 80053 | Comprehensive metabolic panel | <1% | 30,410 | $32K |
| 99495 | <1% | 555 | $30K | |
| 77080 | <1% | 570 | $29K | |
| 73562 | <1% | 2,344 | $28K | |
| 72100 | <1% | 2,187 | $27K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 2,175 | $27K |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 374 | $26K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 54 | $26K |
| 73221 | <1% | 194 | $26K | |
| 86900 | <1% | 11,297 | $25K | |
| 73610 | <1% | 4,047 | $25K | |
| 73630 | <1% | 4,736 | $25K | |
| 74178 | <1% | 209 | $24K | |
| 70491 | <1% | 264 | $23K | |
| 97165 | <1% | 657 | $23K | |
| 88304 | <1% | 2,223 | $22K | |
| 86780 | <1% | 568 | $20K | |
| 88307 | <1% | 483 | $19K | |
| 74018 | <1% | 2,631 | $19K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 2,026 | $18K |
| 73130 | <1% | 3,841 | $18K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 4,450 | $18K |
| 88342 | <1% | 1,211 | $17K | |
| 90674 | <1% | 594 | $17K | |
| 74019 | <1% | 1,978 | $17K | |
| 90670 | <1% | 258 | $16K | |
| 29125 | <1% | 692 | $16K | |
| 96160 | <1% | 1,476 | $15K | |
| 73110 | <1% | 2,462 | $15K | |
| 93350 | <1% | 51 | $14K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 1,091 | $14K |
| 93880 | <1% | 218 | $13K | |
| 90656 | <1% | 752 | $12K | |
| 12011 | <1% | 424 | $12K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 223 | $12K |
| 90651 | <1% | 227 | $12K | |
| 99406 | <1% | 830 | $11K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 43 | $11K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 163 | $11K |
| 99386 | <1% | 405 | $11K | |
| 90732 | <1% | 99 | $10K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 864 | $10K |
| 19083 | <1% | 12 | $8K | |
| 73700 | <1% | 170 | $8K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 11,154 | $8K |
| 97116 | <1% | 1,608 | $7K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 7,010 | $7K |
| 72197 | <1% | 27 | $7K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 620 | $7K |
| 76881 | <1% | 126 | $7K | |
| 64415 | <1% | 82 | $7K | |
| 72040 | <1% | 708 | $6K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 3,549 | $6K |
| 12002 | <1% | 257 | $6K | |
| 70498 | <1% | 1,428 | $6K | |
| 29515 | <1% | 67 | $6K | |
| 0003A | <1% | 160 | $6K | |
| 73590 | <1% | 1,619 | $5K | |
| A9270 | Non-covered item or service | <1% | 176,817 | $5K |
| 80051 | <1% | 4,812 | $5K | |
| 64447 | <1% | 160 | $5K | |
| 73080 | <1% | 1,032 | $5K | |
| 90688 | <1% | 291 | $5K | |
| 76000 | <1% | 658 | $5K | |
| 72050 | <1% | 133 | $5K | |
| 72170 | <1% | 1,609 | $4K | |
| 86920 | <1% | 422 | $4K | |
| 94010 | <1% | 167 | $4K | |
| 90756 | <1% | 170 | $4K | |
| 90661 | <1% | 247 | $4K | |
| 73560 | <1% | 622 | $4K | |
| 73140 | <1% | 694 | $4K | |
| 0001A | <1% | 114 | $4K | |
| 97035 | <1% | 688 | $4K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 89 | $4K |
| 71101 | <1% | 522 | $4K | |
| 93308 | <1% | 66 | $4K | |
| 83037 | <1% | 849 | $3K | |
| 99496 | <1% | 56 | $3K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 85,422 | $3K |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 366 | $3K |
| 81025 | <1% | 23,343 | $3K | |
| 0002A | <1% | 85 | $3K | |
| Q0112 | All potassium hydroxide (koh) preparations | <1% | 680 | $3K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,034 | $3K |
| 97163 | <1% | 66 | $3K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 17,171 | $3K |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | <1% | 66 | $3K |
| 90677 | <1% | 14 | $3K | |
| 90461 | <1% | 771 | $2K | |
| 82565 | <1% | 5,167 | $2K | |
| 93976 | <1% | 69 | $2K | |
| 85610 | <1% | 15,995 | $2K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 16,737 | $2K |
| 73090 | <1% | 826 | $2K | |
| 84484 | <1% | 26,366 | $2K | |
| 93225 | <1% | 37 | $2K | |
| 85379 | <1% | 6,019 | $2K | |
| 72128 | <1% | 95 | $2K | |
| 73070 | <1% | 207 | $2K | |
| 74022 | <1% | 6,262 | $2K | |
| 76882 | <1% | 56 | $2K | |
| 77091 | <1% | 57 | $2K | |
| 97012 | <1% | 343 | $2K | |
| 88341 | <1% | 297 | $2K | |
| 76818 | <1% | 35 | $2K | |
| 0012A | <1% | 47 | $2K | |
| 95867 | <1% | 739 | $2K | |
| G0008 | Administration of influenza virus vaccine | <1% | 455 | $2K |
| 96376 | <1% | 9,726 | $2K | |
| J1815 | Injection, insulin, per 5 units | <1% | 7,507 | $2K |
| 81002 | <1% | 7,196 | $1K | |
| 82962 | <1% | 3,810 | $1K | |
| 0011A | <1% | 51 | $1K | |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | <1% | 166 | $1K |
| 83050 | <1% | 125 | $1K | |
| 86850 | <1% | 9,152 | $1K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 519 | $1K |
| 88112 | <1% | 74 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,442 | $1K |
| 0124A | <1% | 42 | $1K | |
| 76820 | <1% | 443 | $1K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 8,987 | $1K |
| 70470 | <1% | 12 | $1K | |
| 85027 | <1% | 18,577 | $1K | |
| 97014 | <1% | 138 | $1K | |
| 84702 | <1% | 8,789 | $1K | |
| 90662 | <1% | 74 | $992.33 | |
| 97166 | <1% | 24 | $881.40 | |
| 0013A | <1% | 23 | $870.55 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,046 | $860.75 |
| 83880 | <1% | 5,597 | $858.16 | |
| 85730 | <1% | 12,447 | $839.75 | |
| 88142 | <1% | 56 | $815.07 | |
| 36416 | <1% | 3,376 | $810.07 | |
| 86580 | <1% | 154 | $791.91 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 3,683 | $752.24 |
| 73552 | <1% | 162 | $713.53 | |
| 73060 | <1% | 128 | $654.28 | |
| 86901 | <1% | 11,282 | $576.31 | |
| 83735 | <1% | 29,093 | $532.37 | |
| 82247 | <1% | 1,750 | $492.77 | |
| 73600 | <1% | 44 | $489.85 | |
| 72070 | <1% | 24 | $482.28 | |
| 82948 | <1% | 117 | $480.74 | |
| 88311 | <1% | 163 | $472.90 | |
| J2359 | Injection, olanzapine, 0.5 mg | <1% | 44 | $469.16 |
| 81003 | <1% | 28,413 | $465.96 | |
| 95937 | <1% | 347 | $408.02 | |
| 99493 | <1% | 12 | $404.62 | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 1,013 | $400.00 |
| 87070 | <1% | 5,056 | $345.46 | |
| 73620 | <1% | 91 | $339.09 | |
| 73000 | <1% | 15 | $338.31 | |
| 93325 | <1% | 625 | $330.00 | |
| 90715 | <1% | 968 | $314.03 | |
| 82248 | <1% | 2,106 | $295.45 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 8,914 | $284.96 |
| 70360 | <1% | 219 | $280.57 | |
| 93270 | <1% | 26 | $274.26 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 3,242 | $269.94 |
| 84520 | <1% | 3,747 | $263.12 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 1,748 | $250.00 |
| 86140 | <1% | 2,883 | $237.67 | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 13 | $234.36 |
| 81001 | <1% | 23,988 | $230.55 | |
| J2704 | Injection, propofol, 10 mg | <1% | 13,904 | $226.45 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 10,713 | $220.25 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 39,745 | $211.43 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 943 | $209.83 |
| 82728 | <1% | 1,495 | $207.95 | |
| 84703 | <1% | 1,109 | $205.12 | |
| 73100 | <1% | 28 | $193.77 | |
| 86592 | <1% | 105 | $188.57 | |
| 87040 | <1% | 3,992 | $157.42 | |
| 84450 | <1% | 2,872 | $155.72 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 3,106 | $154.92 |
| 84460 | <1% | 2,788 | $150.19 | |
| 87186 | <1% | 2,321 | $149.59 | |
| 85651 | <1% | 1,760 | $147.47 | |
| 83615 | <1% | 2,129 | $146.65 | |
| 90658 | <1% | 12 | $139.86 | |
| 73120 | <1% | 39 | $130.10 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 28 | $128.25 |
| 83605 | <1% | 5,811 | $126.79 | |
| 83690 | <1% | 20,559 | $121.41 | |
| 87077 | <1% | 2,005 | $120.67 | |
| 98928 | <1% | 14 | $119.68 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 4,505 | $118.66 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 46,249 | $107.84 |
| 93320 | <1% | 265 | $106.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 31,074 | $98.75 |
| 84439 | <1% | 469 | $98.20 | |
| 80076 | <1% | 5,846 | $95.64 | |
| 84100 | <1% | 8,089 | $94.87 | |
| 94761 | <1% | 1,126 | $86.00 | |
| 87088 | <1% | 2,696 | $83.62 | |
| 82570 | <1% | 835 | $83.08 | |
| Q2035 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) | <1% | 15 | $81.59 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 159 | $78.65 |
| 94799 | <1% | 199 | $69.39 | |
| 87205 | <1% | 1,479 | $69.38 | |
| 82607 | <1% | 302 | $68.98 | |
| 82805 | <1% | 125 | $65.22 | |
| 76870 | <1% | 334 | $65.05 | |
| 94760 | <1% | 1,784 | $64.00 | |
| 84145 | <1% | 801 | $58.52 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 13,594 | $54.29 |
| 84156 | <1% | 711 | $51.85 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 8,767 | $39.17 |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 19 | $38.77 |
| 82550 | <1% | 2,323 | $38.34 | |
| 82150 | <1% | 2,817 | $37.51 | |
| 84550 | <1% | 523 | $35.25 | |
| 85045 | <1% | 460 | $34.63 | |
| 96127 | <1% | 15 | $33.64 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 1,711 | $27.55 |
| 83550 | <1% | 176 | $26.57 | |
| 94664 | <1% | 250 | $24.68 | |
| 86308 | <1% | 580 | $24.52 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 10,993 | $22.44 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 416 | $22.11 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 622 | $22.08 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 5,158 | $20.85 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 8,167 | $18.78 |
| 82746 | <1% | 39 | $16.40 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 17,066 | $16.28 |
| 84075 | <1% | 1,364 | $16.06 | |
| 81015 | <1% | 2,687 | $14.64 | |
| 83986 | <1% | 145 | $14.00 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 2,256 | $12.37 |
| 81000 | <1% | 106 | $12.27 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 15,902 | $12.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 7,506 | $11.56 |
| 82010 | <1% | 826 | $11.23 | |
| 82375 | <1% | 124 | $10.20 | |
| J1836 | Injection, metronidazole, 10 mg | <1% | 152 | $9.86 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 1,837 | $9.53 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 5,812 | $7.62 |
| 90633 | <1% | 68 | $7.00 | |
| 82310 | <1% | 77 | $6.48 | |
| 85384 | <1% | 122 | $5.23 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 12,105 | $5.10 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 14,302 | $4.11 |
| 87081 | <1% | 28 | $3.63 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 4,168 | $3.47 |
| J3490 | Unclassified drugs | <1% | 13,749 | $3.05 |
| 87210 | <1% | 26 | $2.96 | |
| J1920 | Injection, labetalol hydrochloride, 5 mg | <1% | 189 | $1.55 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 13,809 | $1.55 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 2,643 | $0.43 |
| J2800 | Injection, methocarbamol, up to 10 ml | 0% | 677 | $0.00 |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 0% | 673 | $0.00 |
| A6209 | Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | 0% | 69 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 1,406 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 2,264 | $0.00 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 0% | 1,459 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 1,361 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 774 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 641 | $0.00 |
| 87075 | 0% | 63 | $0.00 | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 0% | 25 | $0.00 |
| 90700 | 0% | 26 | $0.00 | |
| 76942 | 0% | 1,291 | $0.00 | |
| C1776 | Joint device (implantable) | 0% | 149 | $0.00 |
| 90734 | 0% | 44 | $0.00 | |
| 99053 | 0% | 71 | $0.00 | |
| 91312 | 0% | 42 | $0.00 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 0% | 85 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 331 | $0.00 |
| 85347 | 0% | 200 | $0.00 | |
| 80164 | 0% | 198 | $0.00 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 275 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 194 | $0.00 |
| 91300 | 0% | 423 | $0.00 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0% | 456 | $0.00 |
| 90710 | 0% | 12 | $0.00 | |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 0% | 268 | $0.00 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 0% | 40 | $0.00 |
| 90714 | 0% | 27 | $0.00 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 101 | $0.00 |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 40 | $0.00 |
| J1245 | Injection, dipyridamole, per 10 mg | 0% | 99 | $0.00 |
| J1953 | Injection, levetiracetam, 10 mg | 0% | 101 | $0.00 |
| A6457 | Tubular dressing with or without elastic, any width, per linear yard | 0% | 68 | $0.00 |
| 84295 | 0% | 13 | $0.00 | |
| 80074 | 0% | 16 | $0.00 | |
| 82374 | 0% | 13 | $0.00 | |
| 76377 | 0% | 559 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 8,960 | $0.00 |
| 99214 | Doctor's office visit, returning patient (more involved) | 0% | 29 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 9,825 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 0% | 1,330 | $0.00 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 0% | 1,520 | $0.00 |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 0% | 2,983 | $0.00 |
| 95940 | 0% | 876 | $0.00 | |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | 0% | 618 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 2,631 | $0.00 |
| J7121 | 5% dextrose in lactated ringers infusion, up to 1000 cc | 0% | 1,411 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 2,310 | $0.00 |
| A9585 | Injection, gadobutrol, 0.1 ml | 0% | 1,028 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 1,456 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 2,699 | $0.00 |
| J3230 | Injection, chlorpromazine hcl, up to 50 mg | 0% | 47 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 3,229 | $0.00 |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 0% | 941 | $0.00 |
| C1769 | Guide wire | 0% | 2,906 | $0.00 |
| A6197 | Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing | 0% | 4,622 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 832 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 0% | 656 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 392 | $0.00 |
| J3411 | Injection, thiamine hcl, 100 mg | 0% | 196 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 165 | $0.00 |
| 87340 | 0% | 38 | $0.00 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 0% | 202 | $0.00 |
| A6022 | Collagen dressing, sterile, size more than 16 sq. in. but less than or equal to 48 sq. in., each | 0% | 1,002 | $0.00 |
| G8987 | Self care functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 88 | $0.00 |
| 84132 | 0% | 13 | $0.00 | |
| 85018 | 0% | 13 | $0.00 | |
| C1889 | Implantable/insertable device, not otherwise classified | 0% | 30 | $0.00 |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 0% | 44 | $0.00 |
| J3360 | Injection, diazepam, up to 5 mg | 0% | 343 | $0.00 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 0% | 40 | $0.00 |
| 91301 | 0% | 155 | $0.00 | |
| 82435 | 0% | 13 | $0.00 | |
| 94644 | 0% | 87 | $0.00 | |
| A4648 | Tissue marker, implantable, any type, each | 0% | 37 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 139 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 0% | 100 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 34 | $0.00 |
| C1781 | Mesh (implantable) | 0% | 13 | $0.00 |
| 90647 | 0% | 78 | $0.00 | |
| G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 45 | $0.00 |
| J0456 | Injection, azithromycin, 500 mg | 0% | 31 | $0.00 |
| 90723 | 0% | 32 | $0.00 | |
| 73503 | 0% | 29 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAMSCHRODER, ROBIN (PRESIDENT, VAL BASED ENT & CFO)
| Provider | Location | Paid |
|---|---|---|
| Henry Ford Health System | Detroit, MI | $334.91M |
| Henry Ford Health ST. John Hospital | Chicago, IL | $159.41M |
| Henry Ford Wyandotte Hospital | Wyandotte, MI | $60.54M |
| Henry Ford Health Macomb Oakland Hospital | Warren, MI | $59.25M |
| W.A. Foote Memorial Hospital | Jackson, MI | $41.32M |
| Henry Ford Macomb Hospital Corporation | Clinton Twp, MI | $40.96M |
| Henry Ford Health Genesys Hospital | Grand Blanc, MI | $31.39M |
| Henry Ford Health Macomb Oakland Hospital | Madison Heights, MI | $24.76M |
| Henry Ford Health System | West Bloomfield, MI | $19.27M |
| Henry Ford Health Rochester Hospital | Rochester, MI | $11.98M |
| Henry Ford Health River District Hospital | East China, MI | $4.59M |
| W.A. Foote Memorial Hospital | Jackson, MI | $2.11M |
| Henry Ford Health Providence Hospital | Novi, MI | $255K |
| Henry Ford Health ST. John Hospital | Detroit, MI | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.